Research
Research hub
Sources by compound
17 of 17 compounds
- SemaglutideFDA-approved
GLP-1 receptor agonist · Metabolism
- TirzepatideFDA-approved
GIP/GLP-1 receptor agonist · Metabolism
- LiraglutideFDA-approved
GLP-1 receptor agonist · Metabolism
- BPC-157Compounding under review
Synthetic pentadecapeptide · Recovery & tissue · 2 FDA-sourced updates
- TB-500Compounding under review
Thymosin β4 fragment · Recovery & tissue · 2 FDA-sourced updates
- KPVCompounding under review
α-MSH tripeptide fragment · Immune system · 2 FDA-sourced updates
- MOTS-cCompounding under review
Mitochondrial-derived peptide · Longevity · 2 FDA-sourced updates
- EpitalonCompounding under review
Synthetic tetrapeptide · Longevity · 2 FDA-sourced updates
- SemaxCompounding under review
Synthetic heptapeptide · Brain & sleep · 2 FDA-sourced updates
- DSIPCompounding under review
Nonapeptide · Brain & sleep · 2 FDA-sourced updates
- GHK-CuCompounding under review
Copper-binding tripeptide · Skin · 1 FDA-sourced update
- LL-37Compounding under review
Cathelicidin antimicrobial peptide · Immune system · 1 FDA-sourced update
- DihexaCompounding under review
Angiotensin IV analogue · Brain & sleep · 1 FDA-sourced update
- PEG-MGFCompounding under review
IGF-1 splice variant, pegylated · Muscle & growth · 1 FDA-sourced update
- Melanotan IICompounding under review
Melanocortin receptor agonist · Skin · 1 FDA-sourced update
- TesamorelinFDA-approved
GHRH analogue · Muscle & growth
- TeriparatideFDA-approved
Parathyroid hormone analogue · Hormones & bone
Not all evidence is equal
A search returns everything: cell studies, animal studies, small human trials and large ones. Before trusting a result, place it on the ladder. On our profiles, every reviewed claim carries one of these levels, and regulatory status is always shown separately.
Weakest to strongest. Hover a level to see what it means.
Read research with confidence
Coming next: reviewed summaries
We're building plain-English summaries of key studies: what was tested, in whom, what was found and the limits, each linked to the original and checked by a named reviewer before it appears. Until then, the links above take you to the sources themselves.
Follow regulatory changes on News & approvals.